TG Therapeutics
TGTX
TGTX
255 hedge funds and large institutions have $1.67B invested in TG Therapeutics in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 92 increasing their positions, 67 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
7% more funds holding
Funds holding: 238 → 255 (+17)
1.96% more ownership
Funds ownership: 58.4% → 60.36% (+2%)
Holders
255
Holding in Top 10
6
Calls
$49M
Puts
$35.3M
Top Buyers
| 1 | +$45.8M | |
| 2 | +$32.7M | |
| 3 | +$17.5M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.8M |
| 5 |
Goldman Sachs
New York
|
+$12.7M |
Top Sellers
| 1 | -$49.3M | |
| 2 | -$32.3M | |
| 3 | -$17.6M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$16M |
| 5 |
Renaissance Technologies
New York
|
-$8.48M |